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Lipid droplets are ubiquitous triglyceride and sterol ester storage organelles required for energy storage homeostasis
and biosynthesis. Although little is known about lipid droplet formation and regulation, it is clear that members of the
PAT (perilipin, adipocyte differentiation related protein, tail interacting protein of 47 kDa) protein family coat the
droplet surface and mediate interactions with lipases that remobilize the stored lipids. We identified key Drosophila
candidate genes for lipid droplet regulation by RNA interference (RNAi) screening with an image segmentation-based
optical read-out system, and show that these regulatory functions are conserved in the mouse. Those include the
vesicle-mediated Coat Protein Complex I (COPI) transport complex, which is required for limiting lipid storage. We
found that COPI components regulate the PAT protein composition at the lipid droplet surface, and promote the
association of adipocyte triglyceride lipase (ATGL) with the lipid droplet surface to mediate lipolysis. Two compounds
known to inhibit COPI function, Exo1 and Brefeldin A, phenocopy COPI knockdowns. Furthermore, RNAi inhibition of
ATGL and simultaneous drug treatment indicate that COPI and ATGL function in the same pathway. These data
indicate that the COPI complex is an evolutionarily conserved regulator of lipid homeostasis, and highlight an
interaction between vesicle transport systems and lipid droplets.
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Introduction
Lipid homeostasis is critical in health and disease, but
remains poorly understood (for review see [1]). Non-esteriﬁed
free fatty acid (NEFA) is used for energy generation in beta-
oxidation, membrane phospholipid synthesis, signaling, and
in regulation of transcription factors such as the peroxisome
proliferator-activated receptors (PPARs). Essentially all cells
take up excess NEFA and convert it to energy-rich neutral
lipids in the form of triglycerides (TG). TG is packaged into
specialized organelles called lipid droplets. NEFA is regen-
erated from lipid droplet stores to meet metabolic and
energy needs, and lipid droplets protect cells against lip-
otoxicity by sequestering excess NEFA. Lipid droplets are the
main energy storage organelles and are thus central to our
understanding of energy homeostasis. Despite their impor-
tance, we know very little about the ontogeny and regulation
of these organelles.
Lipid droplets are believed to form in the ER membrane by
incorporating a growing TG core between the leaﬂets of the
bilayer, and ultimately are released surrounded by a
phospholipid monolayer. Cytosolic lipid droplets possess a
protein coat and grow by synthesis of TG at the lipid droplet
surface [2] and by fusion with other lipid droplets [3].
Formation of nascent droplets and aggregation of existing
droplets is likely to require a dynamic exchange of lipids and
proteins from and to the droplet. Indeed, the range of
proteins identiﬁed in lipid droplet proteomic studies suggests
extensive trafﬁcking between lipid droplets and other cellular
compartments, including the endoplasmic reticulum (ER) [4–
6]. Additionally, lipid droplet-associated proteins translocate
between the cytosol and lipid droplets [7]. For example, tail
interacting protein of 47 kDa (TIP47) associates with small,
putative nascent, lipid droplets [8–10], but is not found on
larger droplets, which are coated by other members of the
perilipin, adipocyte differentiation related protein (ADRP),
TIP47 (PAT) protein family. Intriguingly, TIP47 mediates
mannose 6-phosphate receptor trafﬁcking between the
lysosome and Golgi [11], raising the possibility that trafﬁcking
is involved in lipid droplet ontogeny or fate. However, unlike
the well-studied Golgi trafﬁcking system, the routes to and
from the lipid droplet are unknown.
Once lipid droplets are formed, stored TG is mobilized in a
regulated manner. Triglyceride, diglyceride (DG), and mono-
glyceride lipases convert TG back into NEFA. Most of our
knowledge concerning lipolysis is based on extensively
studied adipocytes in which at least two lipolytic enzymes
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PLoS BIOLOGYhave been identiﬁed: adipocyte triglyceride lipase (ATGL)
[12–14] and hormone sensitive lipase (HSL) [15]. Due to the
hydrophobic properties of the lipid droplet TG core, lipases
are likely to act at the surface of lipid droplets [16], where
members of the PAT protein family regulate lipase access to
the TG core. Mammalian genomes encode at least ﬁve PAT-
proteins. Whereas perilipin is the dominant PAT protein in
adipocytes, ADRP is the dominant PAT protein in non-
adipose tissues in which it is tightly associated with the lipid
droplet surface [17]. PAT members appear to have a
hierarchical afﬁnity for the lipid droplet surface. In non-
mammalian genomes, there are fewer PAT proteins. For
example, two PAT proteins termed lipid storage droplet 1
and 2 (LSD-1 and LSD-2) are found in Drosophila melanogaster
[10]. The crucial role of PAT proteins is evolutionary
conserved as the absence of perilipin in mice [18,19], or
LSD-2 in ﬂies [20,21] results in lean animals. Overexpression
of LSD-2 results in obese ﬂies [20]. These data indicate the
conserved PAT proteins at the lipid droplet surface are
important regulators of energy storage.
It seems likely that PAT proteins protect lipid from
lipolysis, but the role of PAT proteins may not be limited to
passive steric hindrance of lipase access to the TG core, as
illustrated by perilipin. Unphosphorylated perilipin protects
the lipid droplet from lipase activity. Following stimulation
by protein kinase A (PKA), however, phospho-perilipin acts
as a docking site for HSL [22,23], which translocates from
the cytosol to the droplet surface [24]. Whereas phospho-
perilipin promotes massive NEFA release from the droplet,
this is not mediated exclusively by HSL, as mice lacking HSL
function show a relatively mild phenotype marked by the
accumulation of DG, thus demonstrating that HSL acts as a
DG lipase in vivo [25]. The TG lipase functioning in HSL
null mice is ATGL. In the current view of adipocyte lipolysis,
ATGL is responsible for the ﬁrst step in TG hydrolysis,
liberating DG and NEFA, whereas HSL acts as a DG lipase.
We know very little about how ATGL is targeted to the lipid
droplet.
In contrast to the lean phenotype in animals lacking
perilipin (mouse) or LSD-2 (ﬂy), both mice and ﬂies lacking
ATGL are obese. In mice, the absence of ATGL results in
excessive TG accumulation in liver and muscle [12,14].
Similarly, human patients suffering from neutral lipid storage
disease carry mutations resulting in truncated ATGL iso-
forms [26]. ATGL function is evolutionary conserved, as ﬂies
lacking the Drosophila ATGL ortholog, Brummer, accumulate
copious amounts of body fat [13]. The lipid droplet-
associated protein Comparative Gene Identiﬁcation-58
(CGI-58) acts as an ATGL colipase [27]. Mutations in the
CGI-58 gene result in ectopic fat accumulation in patients
suffering from Chanarin Dorfman Syndrome (CDS, [28]),
supporting the idea that both ATGL and CGI-58 are required
for mobilizing lipid stores in nonadipose tissue. Interestingly,
CGI-58 physically interacts with perilipin as demonstrated by
both coimmunoprecipitation and ﬂuorescence resonance
energy transfer (FRET) studies [22,29,30]. In addition, there
are other lipases and probably many more cofactors encoded
in the genome. Understanding which ones act at the lipid
droplet surface and how their localization is regulated will be
important.
Drosophila is a powerful model for pathway discovery due to
well-developed genetics. Additionally, greater than 60% of
the genes associated with human disease have clear orthologs
in Drosophila [31]. Drosophila is highly relevant to lipid droplet
study, as lipid droplets in Drosophila and mammals are
associated with many of the same proteins [4–6,32–35].
Finally, the emerging model of lipid storage and endocrine
regulation are similar in humans and Drosophila [36], suggest-
ing that Drosophila will be a good genetic model for lipid
storage and lipid storage diseases in humans. We therefore
utilized genome-wide RNA interference (RNAi) screening in
Drosophila tissue culture cells to identify and characterize
novel regulators of lipid storage. We then tested for the
function of these regulators in mouse lipid droplet regulation
by directed RNAi studies. We identiﬁed 318 Drosophila genes
required to limit lipid storage and 208 Drosophila genes
required to promote lipid storage. These genes encode
known regulators of lipid storage as well as genes not
previously associated with lipid storage regulation.
Because the protein composition of the lipid droplet
surface is so critical for lipid droplet function, and because
very little is known about how lipid droplet decoration is
regulated, we focused on the exciting ﬁnding that the
retrograde vesicle-trafﬁcking machinery, utilizing the Coat
Protein Complex I (COPI) and COPI regulators, was required
to utilize lipid stores. COPI subunit knockdown by RNAi, as
well as COPI inhibition with compounds, resulted in increased
lipid storage both in Drosophila and mouse tissue culture cells,
demonstrating evolutionary conservation of our ﬁndings.
COPI and COPII vesicles are essential components of the
trafﬁcking machinery cycling between the ER and Golgi
(reviewed in, e.g., [37]). COPI vesicles mediate cargo transport
from the Golgi back to the ER, including escaped ER-resident
proteins. The anterograde counterpart, COPII, mediates
transport of proteins and lipids from the ER to the Golgi.
Whereas interference with either COPI or COPII complexes
disrupts Golgi function [38,39], only COPI was required for
lipid droplet utilization, clearly demonstrating that COPI and
not general Golgi function is required for TG utilization.
Although we certainly do not rule out communication
between the Golgi and lipid droplet, we suggest that there
is a novel ER/lipid droplet trafﬁcking system using a subset of
the ER/Golgi transport machinery.
We found that the basis for lipid overstorage following
COPI knockdown was a decreased lipolytic rate. Using our
existing knowledge of the PAT family members and lipases in
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Author Summary
Fat cells, and cells in general, convert fatty acids into triglycerides
that are stored in droplets for future use. Despite the enormous
importance of lipid droplets in obesity and other disease processes,
we know very little about how lipid reserves in droplets are formed
and how those reserves are drawn down. We have used the model
fruit fly Drosophila to identify candidate regulators of lipid storage
and utilization, and have shown that many of these candidates have
functions that are conserved in mammals. We focused our attention
on a vesicle-trafficking pathway that we show is required for the
modulation of the types of regulatory and enzymatic proteins found
on the lipid droplet surface. Interfering with the function of this
trafficking system with either RNA interference or small-molecule
compounds alters lipid storage. The understanding of this new
pathway, as well as the specific reagents we used, may ultimately
lead to new therapeutics.the regulation of lipolysis, we examined changes in protein
composition at the lipid droplet surface. Interestingly, we
found that interfering with the COPI pathway results in
ectopic accumulation of TIP47 at the lipid droplet surface.
Furthermore, ATGL at the lipid droplet surface was greatly
reduced. Combining the effects of ATGL knockdown and
compounds affecting COPI function did not elicit a stronger
decrease in lipolysis, indicating that ATGL and COPI are
both part of the same lipolytic pathway. Thus, our studies
provide a functional link between COPI retrograde trafﬁck-
ing and the proteins at the lipid droplet surface. More
generally, these results indicate that Drosophila RNAi screen-
ing is suited to detect uncharted pathways affecting NEFA
regulation and to achieve a deeper understanding of cellular
lipid droplet regulation.
Results
Genome-Wide RNAi to Identify Regulators of Lipid
Storage in Drosophila
Lipid droplets are well studied in mammalian cells, but
Drosophila cells have not been extensively used in lipid droplet
studies. Lipid droplets are ubiquitous organelles, and we
found that Drosophila S2 and SL2 (unpublished data), as well as
S3 and Kc167 cells (this study) accumulated TG in lipid
droplets in the presence of excess NEFA. Kc167 cells, for
example, stored little lipid when grown on standard media
(Figure 1A), whereas in the presence of NEFA (400 lM oleic
acid), they readily (within 12 h) accumulated TG packaged in
droplets (Figure 1B), which we visualized with the lipid-
speciﬁc dye BODIPY493/503 [40].
Treatment of Drosophila cells with double-stranded RNA
(dsRNA) decreases, or ‘‘knocks down,’’ transcript levels for
genes sharing the dsRNA sequence, a process known as RNAi
[41]. To help determine whether Drosophila tissue culture is a
good model for lipid droplet function, we used RNAi to
target genes encoding known lipid droplet regulators. Flies or
mice lacking ATGL store more TG than wild type (‘‘over-
storage’’) [12–14], whereas those lacking diacylglycerol acyl
transferase1 (Dgat1), a key enzyme in TG synthesis [42,43],
store less lipid (‘‘understorage’’). Knockdown of bmm, which
encodes Drosophila ATGL, increased lipid storage as expected
(Figure 1C and 1D). Conversely, treating cells with dsRNA
targeting midway (mdy), which encodes Drosophila Dgat1,
decreased lipid storage (Figure 1E and 1F). Thus, Drosophila
cells can be used to analyze gene functions necessary to
increase as well as decrease lipid storage.
Although differences in lipid storage are often obvious, we
were interested in generating a fully quantitative dataset to
support future meta-analysis. To systematically identify and
characterize the genes involved in lipid storage, we developed
a microscopy-based quantiﬁcation method based on image
segmentation and measurement of nuclear to lipid droplet
cross-sectional area (see Figure 2A–2D and Materials and
Methods). This technique allowed us to detect lipid storage
differences caused by the different feeding conditions and
control dsRNA treatments (Figure 2E). We used this imaging
method to perform a genome-wide RNAi screen with the
well-characterized dsRNA library of the Harvard Drosophila
RNAi Screening Center (DRSC). This collection covered more
than 95% of the predicted Drosophila genes [44]. dsRNAs
against bmm and mdy were included in each screening plate as
controls. We also included wells with no dsRNA and with or
without oleic acid as controls.
As a screening cell line, we used Kc167 cells, which showed
the best balance of lipid droplet deposition, RNAi suscept-
ibility characteristics, and adhesion during assay development
(unpublished data). Following dsRNA treatment of oleic acid-
fed cells and image analysis, ratiometric data were normalized
within plates and across the entire screening collection using
linear models, B-score, Z-score/median absolute deviation
(MAD), and strictly standardized mean difference (SSMD)
[45–48], all of which gave similar results. B-score normal-
ization [46] across the entire screen marginally out-per-
formed other methods (see Materials and Methods, Table S1).
B-score results were used for all analyses reported here.
Rank-order analysis of the genome-wide screening results
demonstrated that the majority of dsRNAs had no effect on
lipid storage. However, two cohorts of dsRNAs resulted in
lipid overstorage, as expected for genes required for
promoting lipid utilization, or understorage, as expected
for genes required for promoting lipid storage (Figure 2F).
Thresholds for determining whether a particular dsRNA
resulted in a phenotype were selected to balance false
negatives and false positives based on the results for bmm,
mdy, and no oleic acid controls. At B-scores   2.0 and    1.7,
greater than 89% of wells treated with dsRNA targeting bmm
or without oleic acid resulted in the correct overstorage or
understorage call, respectively (Figure 2G). Using these
cutoffs, we identiﬁed 208 candidate genes required for
increasing lipid storage (understorage on knockdown, B-
score    1.7, Tables S2 and S9) and 318 required for reducing
Figure 1. Drosophila Cells as a Model of Lipid Storage
(A–F) Drosophila Kc167 cells grown in standard medium (A, C, and E) or
medium supplemented with 400 lM oleic acid complexed to 0.4% BSA
(B, D, and F). Cells were treated with dsRNA targeting brummer (bmm;[ C
and D]) or midway (mdy; [E and F]). The corresponding mouse genes are
Atgl and Dgat-1. Nuclei are shown in blue (stained with Hoechst 33342),
and lipid droplets in green (stained with BODIPY493/503). Scale bar in (A)
represents 10 lm.
doi:10.1371/journal.pbio.0060292.g001
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COPI and Lipid Storagelipid storage or lipid utilization (overstorage on knockdown,
B-score   2.0, Tables S3 and S9). These data suggest that
about 3% of the Drosophila genome is directly or indirectly
involved in lipid storage. All data are available in the
supplement (Table S4) and at http://lipoﬂy.mpibpc.mpg.de/
and http://ﬂyrnai.org.
The most critical test of screen performance is coherence
as measured by the identiﬁcation of multiple genes in a
multisubunit complex or a known pathway [49]. Such
coherent gene sets are also the best candidates for more
detailed analysis. To categorize the dsRNA phenotypes
according to molecular networks, we analyzed the identiﬁed
genes using Gene Ontology (GO) [50] terms with the VLAD
tool [51]. This analysis allows for the detection of statistically
overrepresented GO terms among a set of genes and projects
those enrichments onto the GO-term hierarchy. Genes with a
possible function in lipid storage regulation as detected by
the RNAi screen were tested against the complete Drosophila
gene set for enrichment of GO terms associated with
biological process, molecular function, and cellular compo-
nent. Identiﬁed, enriched terms were structured in hierarch-
ical networks (Figures 3–5; the results are also tabulated in
Table S5). We also took advantage of data from a concurrent
lipid storage screen using an independent dsRNA library and
Drosophila S2 cells [52]. This allows us to develop a robust
overview of lipid droplet storage.
Duplication of extensive RNAi screens using different
libraries on different cell types provides a cross-validating
function that is extremely useful in the analysis of compre-
hensive datasets. The overlap (25%, 57 genes) between the S2
cell screen (227 genes identiﬁed; Table S6) and our genome-
wide study on Kc167 cells (526 genes identiﬁed) was highly
signiﬁcant (p , 1e
 14, Wilcox test). More importantly, the GO
term networks were quite similar and suggest that key
pathways have been identiﬁed (Figure 3). For example, both
screens show that interfering with translation factors and
ribosomes result in lipid storage defects (GO:0022613,
GO:0006412). Additionally, genes resulting in lipid storage
defects are enriched for transcriptional regulators in both
screens (GO:0010467) and trafﬁcking (GO:0006911,
GO:0006890). The only major differences between the screens
were that genes involved in pre-mRNA processing were
Figure 2. RNAi-Mediated Genome-Wide Screening of Drosophila Cells for Lipid Storage Phenotypes
(A and B) Regions of original images from the screen of cells stained with DAPI (A) or the lipid droplet-specific dye BODIPY 493/503 (B).
(C and D) Image segmentation results of the images shown in (A and B). Nuclei and lipid droplet boundaries are depicted.
(E) Sample off-line lipid droplet quantification results by image segmentation. Cells were grown with or without oleic acid and treated with the
indicated dsRNAs. Significant differences between dsRNA treated and untreated cells at p , 0.05 (two-sided t-test) are shown (indicated with an asterisk
[*]). Error bars indicate standard deviation.
(F) Rank-order plot of the normalized screen results where positive B-scores indicate overstorage and negative B-scores indicate understorage.
(G) Performance of controls incorporated in the on-line screening plates. Black bars represent overstorage (B-score . 2.0), and light grey bars represent
understorage phenotypes (B-score ,  1.7).
doi:10.1371/journal.pbio.0060292.g002
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proteasome function were enriched in the S2 cell screen.
However, ﬁve genes required for lipid storage in our study
(suppressor of deltex, ubiquitin conjugating enzyme 2, ubiquitin
activating enzyme 1, Roc1a, and Roc1b) are involved in ubiquitin-
mediated proteolysis at the proteasome [53]. Thus, the
screens are largely cross-validating.
Gene knockdowns resulting in understorage have a
candidate wild-type function in promoting lipid storage.
Whereas we identiﬁed gene functions linked to neutral lipid
synthesis (Table S5), the most striking enrichments were for
regulatory functions within the nucleus (Figure 4). GO terms
associated with the nuclear functions transcription or tran-
script processing were particularly prominent (Figure 4).
Figure 4. Enriched GO Terms among the Genes Promoting Lipid Storage
GO-based functional classification ([A] GO: molecular function; [B] GO: cellular component, and [C] GO: biological process) of genes resulting in lipid
understorage phenotypes when targeted by dsRNAs (208 genes). For details, see main text and legend of Figure 3.
doi:10.1371/journal.pbio.0060292.g004
Figure 3. Independent, Genome-Wide RNAi Screens Identify Similar Sets of Genes Regulating Lipid Storage
GO-based functional classification (GO: biological process) of genes resulting in lipid storage phenotypes upon targeting by dsRNAs of the present (526
genes) as well as a concurrent study (227 genes; [52]). GO terms were organized into networks using the VLAD software (A and B). Node labels include
the associated GO-term identifier and GO-term description as well as the associated p-value reflecting enrichment as compared to the whole-genome
annotation reference set. The number of genes associated with the respective GO term included in the test set as well as the complete-genome
annotation is also shown. A darker node color reflects lower p-values. Yellow stars indicate GO-terms shared by the two genome-wide RNAi screen
datasets.
doi:10.1371/journal.pbio.0060292.g003
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COPI and Lipid StorageThese data suggest that lipid storage requires a complex
regulatory network.
In contrast, the candidate genes required for lipid
utilization were enriched for cytoplasmic functions (Figure
5, Table S5). We found that lipid storage increased after
treatment with dsRNAs targeting genes encoding lipid
droplet-associated proteins (GO:0005811). In addition to
GO term analysis, we directly compared the identiﬁed
candidate lipid storage-modulating genes functions with
genes encoding proteins of the recently described, but
functionally uncharacterized, lipid droplet-associated mam-
malian [5,6,32,35] and Drosophila [4,33] subproteomes, only
some of which have lipid droplet GO terms. These genes were
far more likely to result in a lipid overstorage phenotype
when subjected to knockdown in Drosophila (p . 1e
 16, Wilcox
test) than the reference genome-wide dsRNA targets. This
suggests that many of the genes revealed by our RNAi
experiments encode direct regulators of lipid storage. Gene
functions involved in mitochondrial fatty acid beta-oxida-
tion, which utilize NEFA as a substrate, as well as genes
involved in protein synthesis, were also enriched. Indeed,
knockdown of 12% of the Drosophila genes encoding trans-
lation-related functions (GO:0006412), including 32% of the
genes encoding ribosomal subunits (GO:0033279), resulted in
lipid overstorage (Figure 5, Table S5). It is possible that
decreased ATP demand for protein synthesis and decreased
ATP generation in mitochondria simply decrease the need
for energy in the cells, resulting in increased lipid storage.
Mitochondrial uncoupling and beta-oxidation pathways are
areas of therapeutic interest for diabetes and other metabolic
disorders [54–57].
One of the most striking results was the prevalence of
cellular transport functions in general (GO:0006909,
GO:0006890; and GO:0000022), and the COPI trafﬁcking
pathway mediating Golgi to ER transport in particular,
among the genes resulting in a lipid overstorage phenotype
on knockdown (Figure 5, Table S5). Nascent lipid droplets are
thought to form at the ER and then enlarge and fuse to form
larger droplets [8–10]. Thus, our result is somewhat surpris-
ing, as we expected that wild-type ER functions might be
involved in promoting lipid storage rather than lipid
utilization. Similarly, it is known that lipid droplets are
transported as cargo on microtubules in Drosophila embryos
and that such transport is required for fusion of lipid
droplets in muscle cells [3,58]. There was a strong enrichment
for genes involved in spindle microtubule elongation (Figure
5C) among the genes showing overstorage on knockdown.
Again, whereas microtubule involvement in lipid storage is
predicted, interfering with microtubule cargo transport
might be expected to decrease lipid storage.
To validate a ‘‘gold set’’ of genes ready for extended follow-
up, we selected genes for additional Drosophila treatments
using original and secondary dsRNAs. At least two different
nonoverlapping dsRNAs in our screen or in the Guo et al.
screen [52] resulted in conﬁrmed understorage or over-
storage phenotypes for a subset of candidate genes (Table S7).
Additionally, mouse orthologs of 127 Drosophila genes selected
on the basis of lipid storage phenotypes in Kc167 cells
(including orthologs of 54 genes that failed to pass our
cutoff) were knocked down in two mouse cell lines using short
interfering RNAs (siRNAs). We used a mouse ﬁbroblast cell
line (3T3-L1), in which lipid droplets have been extensively
characterized, and a liver cell line, AML12, which was
previously used as a model of ectopic fat deposition [59].
Retesting in mouse cells is a particularly stringent validation
of the Drosophila dsRNA data as it simultaneously provides
information about evolutionary conservation as well as
obviating concerns about spurious off-target effects
[49,60,61]. The 33 genes resulting in lipid storage defects
when knocked down in both Drosophila and in mouse cells
validate the involvement of many of the biological processes
implicated by the primary screen (Table S7). For example,
knockdown of the Ubiquinol cytochrome c reductase complex III
subunit VII gene (Uqcrq; ortholog of the Drosophila CG7580
gene), which encodes a component of the mitochondrial
respiration chain, results in greatly enlarged AML12 cells
storing dramatically more lipid than control cells (Figure 6A–
6C). Similarly, knockdown of Smarca4 (ortholog of the
Drosophila brahma gene), which encodes a member of the
SWI/SNF chromatin modifying complex [62], results in lipid
overstorage (Figure 6D). Knockdowns of COPI complex
Figure 6. Evolutionary Conserved Lipid Droplet Regulators
Mouse AML12 cells store little lipid in the absence of exogenous NEFA
(A), whereas addition of NEFA to the growth medium induces lipid
droplet deposition (B). Knockdown effects on cellular lipid droplets of the
mouse genes encoding Uqcrq (CG7580 in Drosophila), an electron
transport chain member, and Smarca4 (Brahma in Drosophila), a
chromatin-associated protein (C and D). Nuclei are shown in blue
(stained with Hoechst 33342), lipid droplets in green (stained with
BODIPY493/503). Scale bar in (A) represents 50 lm.
doi:10.1371/journal.pbio.0060292.g006
Figure 5. Enriched GO Terms among the Genes Promoting Lipid Utilization
GO-based functional classification ([A] GO: molecular function; [B] GO: cellular component, and [C] GO: biological process) of genes resulting in lipid
overstorage phenotypes when targeted by dsRNAs (318 genes). For details, see main text and legend of Figure 3.
doi:10.1371/journal.pbio.0060292.g005
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COPI and Lipid Storagemembers resulted in overstorage in Drosophila S2 and Kc167
cells, and in mouse 3T3-L1 and AML12 cells (Table S7).
Although there is much to be gleaned from the screen, we
focused our attention on the Golgi to ER trafﬁcking COPI
complex.
COPI Complex Is a Regulator of Lipid Storage
Overrepresentation of genes encoding ER/Golgi vesicle-
associated proteins among the genes showing a lipid over-
storage phenotype on knockdown suggests that vesicle
trafﬁcking proteins participate in lipid utilization. Most
strikingly, six out of the seven genes encoding COPI subunits
(Figure 7) that mediate retrograde transport from the Golgi
to the ER, showed dramatically increased lipid storage
following dsRNA treatment in the genome-wide RNAi screen
(B-score¼4.6 to 11.1, false discovery rate [FDR]-corrected p¼
1e
 5 to 1e
 34). Enrichment for members of such multisubunit
complexes in RNAi screens has outstanding predictive value
[49]. Our observed enrichment for essentially all the COPI-
associated factors among the knockdowns resulting in lipid
overstorage, strongly suggests that COPI is required for
limiting lipid storage (FDR-corrected p , 1e
 6). In addition,
dsRNAs targeting ADP ribosylation factor at 79F (Arf79F) had the
same effect as COPI knockdown. Arf79F encodes a small G
protein homologous to mammalian Arf1, the key regulator of
COPI vesicle formation at the Golgi [63]. Surprisingly, eCOP
was the only COPI subunit repeatedly failing to produce a
lipid storage phenotype following RNAi in both the S2 [52]
and our Kc167 cell screens. Although this is a negative result,
we suggest that this subunit is not involved in lipid storage
regulation (see Discussion). Interestingly, none of the seven
COPII members required for anterograde transport from the
ER to the Golgi [37,38] showed a lipid accumulation
phenotype following RNAi (Figure 7B; B-score ¼ 0.0 to 1.4,
FDR-p ¼ 0.99 to 0.78), strongly suggesting that lipid over-
storage due to COPI knockdown is not a general consequence
of disrupted trafﬁcking between the ER and Golgi.
In organisms, cells are exposed to differing NEFA levels due
to feeding and fasting. Therefore, to test for the function of
the COPI complex in physiological conditions without
elevated NEFA, we also performed new RNAi experiments
with or without supplementing the media with oleic acid
(Figure 8A–8G; additional data not shown). Even in the
absence of oleic acid, knockdowns of all the members of the
COPI complex that promoted lipid droplet deposition under
fed conditions also promoted accumulation without feeding
(Figure 8A–8G; additional data not shown). Thus, the lipid
storage phenotype was also independent of the nutritional
status of the cells.
To further investigate whether the observed lipid storage
phenotype after the loss of COPI-subunit function is due to a
speciﬁc pathway or a more general effect of interference with
Golgi and ER integrity, we also tested additional dsRNAs
targeting transcripts encoding the COPII-associated proteins
CG10882, Sar1, Sec23, Sec31, and PLD (Figure 8G). Further-
more, the Drosophila genome encodes ﬁve Arf proteins [64],
which we also reinvestigated in additional RNAi experiments.
Arf79F encodes ARF1, which is required for COPI function,
but Arf51F, Arf72A, Arf84F, and Arf102F are not known to be
required for COPI-mediated transport [65]. Only Arf79F
resulted in a mutant lipid droplet phenotype upon RNAi
knockdown (Figure 8G). These experiments demonstrated
that the lipid overstorage phenotype is speciﬁc to COPI loss
of function and raise the possibility that the lipid overstorage
phenotype is Golgi independent.
Although multiple dsRNAs veriﬁed the phenotypic effect of
COPI knockdown, we sought to further validate those results
with an independent technique, to rule out effects based on
the RNAi treatment, or the prolonged incubation time (4 d)
due to the knockdown procedure. Therefore, we also tested
pharmacologically for COPI involvement in lipid storage. We
treated Drosophila S3 cells for 18 h with 24 different
concentrations of Exo1, a selective inhibitor of Arf1 activity
[66], and determined the dose response (Figure 8H). Lipid
droplets were stained with the same dye as for the RNAi
experiments. As in the RNAi experiments, we used internal
controls, including cells with no oleic acid feeding, cells
Figure 7. COPI Is a Regulator of Lipid Storage
(A) Schematic representation of the COPI trafficking pathway (center)
directing traffic from the Golgi (right) to the ER (left). COPII members (not
detailed) direct traffic from the ER to the Golgi. Members showing
increased lipid storage following knockdown in the Drosophila primary
screen are highlighted (red).
(B) Primary screen results for COPI and COPII components are tabulated.
The average B-score for the given gene (higher B-scores indicate more
stored lipid, see Figure 2) as well as the average false discovery rate
(FDR)-corrected p-value are given.
doi:10.1371/journal.pbio.0060292.g007
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COPI and Lipid Storagetreated with the compound solvent, and cells treated with
Triacsin C, a known inhibitor of TG synthesis [67]. Dose-
response curves for Exo1 were determined by enumerating
cells that showed an increase in lipid staining (or relative to
the enumerated cells based on a cytosolic counterstain; inset
in Figure 8H) and expressing this as per cent activity relative
to cells incubated in oleic acid and full inhibited by Triacsin
C. Thus, increased activity indicates lipid overstorage. Treat-
ment of Drosophila S3 cells with Exo1 resulted in a dose-
dependent (half maximal effective concentration [EC50] ¼ 5
Figure 8. The COPI-Mediated Retrograde Trafficking Pathway Is a Negative Regulator of Lipid Storage
(A–F) Drosophila cells with or without oleic acid stained with BODIPY493/503 to detect lipid. Control cells not treated with dsRNA (A and D) or cells
incubated with dsRNAs targeting Arf79F (an Arf1 homolog) (B and E) or aCop (C and F) are shown.
(G) All COPI, and several COPII members as well as additional Arfs, were retested using independent dsRNAs and gave similar results. Results and
number of dsRNAs present in the primary screen (including oleic acid) and retests are given.
(H) Dose response of Drosophila S3 cells to Exo1 (structure inset) showing the %-activity derived either from the lipid specific signal (filled circles [ ]) or
the lipid/cell ratio (open circles [*]). Percent activity refers hereby to the changes of lipid storage relative to Triacsin C treatment, which decreases lipid
storage by blocking TG synthesis (this is analogous to the mdy controls in RNAi experiments, see Material and Methods). Increased activity indicates
increased lipid storage, which increased with concentration.
Scale bar in (A) represents 10 lm.
doi:10.1371/journal.pbio.0060292.g008
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COPI and Lipid StoragelM) increase in lipid storage that was greater than 10-fold.
Thus, multiple dsRNAs targeting COPI and Arf79F mRNAs as
well as Exo1, a compound targeting Arf79F (Arf1 in
mammals), resulted in the same phenotype. These data
strongly indicate that COPI is required to limit lipid storage
in droplets in Drosophila.
COPI Complex Is an Evolutionary Conserved Regulator of
Lipid Storage
To explore the function of COPI in lipid droplet cell
biology in greater detail, we performed additional experi-
ments in the mouse 3T3-L1 and AML12 cells. As positive and
negative controls, we used irrelevant ‘‘ALLStars negative
control’’ siRNAs, or siRNAs targeting transcripts encoding
known lipid droplet regulators, and compared the resulting
cellular phenotypes to the results of parallel siRNA treat-
ments targeting transcripts encoding COPI components. As
in the Drosophila experiments, we required that at least two
siRNAs resulted in the same phenotype.
Like AML12 cells, 3T3-L1 cells also stored little lipid in the
absence of exogenous NEFA (Figure 9A and 9G), whereas
small, clustered lipid droplets appeared upon addition of
oleic acid (Figure 9B and 9H). Depletion of both ADRP and
TIP47 by RNAi resulted in fewer and much larger lipid
droplets (Figure 9C and 9I [68]) relative to wild type (we used
double knockdowns for these controls because single knock-
downs resulted in a minimal phenotype [68]). Conversely,
knockdown of Atgl (bmm in Drosophila) transcripts resulted in
increased lipid storage (Figure 9D and 9J), but no differences
in the appearance of the lipid droplets. Targeting the genes
encoding a, b, b9, c, d,o rf COPI subunits by siRNAs resulted
in increased lipid storage (Figure 9E, 9F, and 9K–9P). As in
the Drosophila knockdown experiments, eCOP knockdown
failed to increase lipid storage (unpublished data). We also
failed to observe a phenotype following knockdown of either
of two genes, sec24 and Pld1, encoding COPII components
(unpublished data). Thus, the Drosophila and mouse RNAi
experiments unambiguously indicate that COPI subunits
(with the exception of eCOP) have evolutionarily conserved
lipid droplet functions.
Both Arf1 and Gbf1, an Arf guanine nucleotide exchange
factor (GEF), are required for COPI recruitment from the
cytosol to Golgi [69]. We also asked whether Arf1 and any of
three pharmacologically related GEFs were required for lipid
utilization. The Gbf1, Big1, and Big2 proteins are GEFs
inhibited by Brefeldin A (BFA) [70]. BFA treatment and
knockdowns of either Arf1 or Gbf1 (the latter conﬁrmed at the
protein level) resulted in lipid overstorage (Figure 9Q and
9R), whereas we observed no lipid overstorage following
knockdown of Big1 or Big2 (unpublished data). Thus the COPI
complex and critical regulators of COPI translocation are
required for lipid utilization.
Loss of COPI Function Results in Decreased Lipolysis
Lipid overstorage in the absence of COPI could be due to
decreased release of NEFA from droplets, or increased
Figure 9. Function of Selected Mouse Orthologs of Genes Showing Lipid Storage Phenotypes in Drosophila Cells
(A–F and M–R) AML12 or 3T3-L1 cells (G–L), with (B–F and H–R), or without (A and G) oleic acid and stained for nuclei (Hoechst 33342) and lipid
(BODIPY493/503). Cells were transfected with ALLStars negative control siRNA (control) or the siRNAs targeting the indicated genes. Drosophila
homologs are given (parentheses). Scale bar in (A) represents 50 lm.
doi:10.1371/journal.pbio.0060292.g009
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COPI and Lipid Storagesynthesis of TG for storage, or both. In order to explore
whether COPI is required for one or both of these general
functions, we measured both NEFA release and esteriﬁcation
of NEFA into TG in AML12 cells (Figure 10A). As expected,
we observed increased release of NEFA from cells treated
with control siRNAs targeting Adrp and Tip47 transcripts,
which is mediated by increased amounts of lipid droplet-
associated ATGL [68]. In contrast, NEFA release decreased
when Atgl lipase transcripts were targeted as controls.
Additionally, we observed increased incorporation of NEFA
into TG following Atgl knockdown, suggesting that the
tremendous increase in TG seen in those cells is due to
decreased NEFA release and continued synthesis of TG
despite the reduced efﬂux. The modest increase in incorpo-
ration of NEFA into TG following COPI knockdown was
insigniﬁcant. However, we observed approximately 40% of
wild-type NEFA release in cells treated with siRNAs targeting
either cCOPI or fCOPI transcripts—in the same range as
after Atgl knockdown (Figure 10A). In separate experiments,
we also observed decreased NEFA release following Gbf1
knockdown, but not following Big1 or Big2 knockdown (Table
S8). These data indicate that COPI is a novel regulator of
lipolysis.
We also asked whether short-term pharmacological inhib-
ition of COPI trafﬁcking phenocopies the COPI knockdown
phenotype in mouse cells, as we noted in Drosophila cells. We
used COPI inhibitors Exo1 and BFA [39,66], both of which
result in increased lipid storage. Both compounds reduced
NEFA release to the same extent as the siRNAs targeting
COPI subunit mRNAs (Figure 10B). To dissect the role of
COPI in lipolysis, we used a combination of siRNAs targeting
different genes in the lipolytic pathway, and Exo1 or BFA
treatment, to mimic genetic epistasis experiments (a proven
tool for dissecting functional relationships between members
of the same or different pathways [71]). Combining siRNA-
mediated knockdown of COPI members and BFA or Exo1
treatment did not enhance the decreased lipolysis phenotype
(Figure10B), indicating that the observed effects following
drug treatment are only COPI mediated. Additionally, these
data suggest that there are no serious compound-based side
effects vis-a-vis lipid droplets, even for the broad-spectrum
inhibitor BFA (also note that other BFA-sensitive GEFs, Big1
and Big2, did not result in a lipid storage phenotype on
knockdown). Decreased lipolysis could be due to decreased
lipase activity at the lipid droplet. To determine whether that
lipase was ATGL, we combined siRNAs targeting ATGL
transcripts and BFA or Exo1 drug treatment (Figure 10B). If
ATGL were responsible, then ATGL knockdown would have
no effect on BFA- or Exo1-treated cells. Indeed, the lipolysis
rate was not further decreased, suggesting that COPI-
mediated lipolysis effects are mediated by ATGL. This
conclusion is further supported by experiments in which we
treated cells with siRNAs targeting ADRP and TIP47 tran-
scripts in combination with either BFA or Exo1. In the
absence of ADRP and TIP47, more ATGL is found at the lipid
droplet surface [68]. We also found that Exo1 or BFA
treatment rescues the effect of ADRP and TIP47 knockdown.
This, along with the ﬁnding that COPI and ATGL are in the
same pathway, suggests that COPI is an important positive
regulator of ATGL.
Loss of COPI Function Results in Altered Lipid Droplet
Protein Composition
Wild-type COPI could mediate release of NEFA from lipid
droplets by altering the heterogeneous and dynamic collec-
tion of lipid droplet-associated proteins found in different
cell types and conditions [72]. To further explore what
happens to lipid droplets following COPI knockdown, we
examined the distribution of TIP47 and ADRP on the lipid
droplet surface. These are the only PAT proteins expressed in
AML12 cells [68]. In control cells incubated with oleic acid,
and control siRNAs, ADRP was associated with the lipid
droplet surface whereas TIP47 was mostly found in smaller
punctate cytoplasmic inclusions and more ill-deﬁned cyto-
plasmic locations ([68] and Figure 11A). TIP47 and ADRP
were not colocalized in untreated cells. Following siRNA
treatments targeting a, b, b9, c, and f COPI subunit or Gbf1
transcripts, both ADRP and TIP47 were observed on the same
lipid droplets (Figure 11B–11H). Treating the cells with BFA
had the same effect on TIP47 localization (Figure 12A and
12B). These data indicate that COPI is required for a wild-
type pattern of PAT localization to the lipid droplet.
PAT proteins are tightly associated with the lipid droplet
Figure 10. NEFA Incorporation and NEFA Release Measured in AML12
Cells after RNAi-Mediated Gene Knockdown and Drug Treatment
(A) Relative activity [(experimental/ALLStars negative control (control)) 
1] in radiolabel assays for TG esterification (nM) (grey bar) and NEFA
release (nM) (black) relative to total protein concentration in cells treated
with siRNAs targeting the indicated transcripts. Significance at p , 0.01,
impaired t-test, is shown (indicated by an asterisk [*]). Standard error is
indicated by the bars.
(B) Relative activity [(experimental/ALLStars negative control (control)
and DMSO)   1] in radiolabel assays for NEFA release (nM) relative to
total protein concentration in cells treated with siRNAs targeting the
indicated transcripts in the presence of DMSO only (open bar), BFA (5
lM) in DMSO (light-grey bar), or Exo1 (5lM) in DMSO (dark-grey bar).
Significance at p , 0.01, impaired t-test, is shown (indicated by an
asterisk [*]). Standard error is indicated by the bars.
doi:10.1371/journal.pbio.0060292.g010
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COPI and Lipid Storagesurface. In order to distinguish localization to the region of
the lipid droplet from true localization to the lipid droplet
surface, we treated cells with BFA after oleic acid feeding, and
isolated lipid droplets by sucrose gradient ultracentrifuga-
tion. This treatment separates the lipid droplets from cytosol
and other membrane fractions. To determine what proteins
were on the lipid droplets, western blots were probed with
antibodies detecting ADRP, TIP47, and ATGL, as well as the
ATGL cofactor CGI-58. Whereas ADRP and CGI-58 remained
quantitatively unchanged after BFA treatment, TIP47 protein
levels in the lipid droplet fraction increased nearly 2-fold
(Figure 12C). There was no change in TIP47 in the cytosolic
fraction (unpublished). The cell-staining experiments showed
a more dramatic increase in TIP47 at the ADRP-positive lipid
droplets than we observed in the western blots, but
importantly, both cell staining and western blotting show
increased TIP47 on COPI inhibition. Strikingly, ATGL levels
decreased to near or below the detection limit, suggesting
that BFA treatment drives ATGL off the lipid droplet surface,
or prevents ATGL association with the lipid droplet (Figure
12C). Thus, both cell staining and analysis of isolated droplets
indicate that wild-type COPI limits abundance of TIP47 at
the lipid droplet surface and is required for ATGL local-
ization to the droplet surface. Taken together with the
epistasis results demonstrating that COPI and ATGL function
in the same pathway, these results indicate that COPI-
mediated targeting of ATGL to the lipid droplet is required
for lipolysis.
Figure 11. TIP47 Translocates to the Lipid Droplet Surface upon Down-Regulation of COPI
Mouse AML12 cells were treated with ALLStars negative control siRNA (control) (A) or siRNAs targeting cCOP (B) for 4 d, respectively. Cells were
incubated with 400 lM oleic acid for 12 h prior to staining with antibodies detecting TIP47 (green channel) or ADRP (red channel). Images of the
separate channels as well as a merged image are shown. (C–H) Merged channel images of similarly treated mouse AML12 cells. Targeted genes are
indicated. Scale bar in (A) represents 50 lm.
doi:10.1371/journal.pbio.0060292.g011
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Positive regulation of lipolysis by the COPI retrograde-
vesicle trafﬁcking pathway was the most striking and
unexpected result of our screen. We have found that
interference with COPI function, either by RNAi or
compounds, in Drosophila Kc167 or S3 cells, or in mouse
3T3-L1 or AML12 cells, results in increased lipid storage.
Furthermore, recent and parallel studies in yeast [73] and
Drosophila S2 cells [52] also suggested a role of COPI function
in lipid droplet regulation. Interestingly, only the e-subunit of
the COPI complex failed to result in a lipid droplet
deposition phenotype on knockdown. Although we cannot
rule out limited RNAi efﬁcacy or increased protein stability,
eCOP was the only canonical COP subunit not resulting in a
lipid storage phenotype in a parallel study using different
cells and reagents [52], and we found that targeting of eCOP
transcripts by RNAi in AML12 cells had a weak effect on lipid
storage at best. Finally, eCOP is the only dispensable subunit
in a recent study identifying COPI activity coupled with fatty
acid biosynthesis as a host factor important for Drosophila C
virus replication [74]. This is especially interesting, as certain
enveloped viruses, including Hepatitis C virus, assemble on
lipid droplets [75,76]. Taken together, these results indicate
that six out of the seven wild-type COPI subunits mediate
lipid storage by positively regulating lipolysis.
COPI could have a direct or indirect effect on lipid storage.
The indirect mechanism is poorly deﬁned, but if the Golgi is a
‘‘sink’’ for phospholipids derived from TG stores, then
decreased Golgi function could simply decrease demand for
TG substrate. If NEFA (from the media in fed cells, and from
biosynthesis in unfed cells) conversion to TG continues, then
increased lipid droplet volume would occur. It is also possible
that canonical COPI function transporting lipids and
proteins from the Golgi to the ER is ultimately responsible
for lipid droplet utilization and protein composition at the
lipid droplet surface. For example, COPI might be required
for the particular phospholipid composition in hemimem-
branes formed on nascent droplets, which secondarily alter
TIP47 and ATGL localization in mature lipid droplets.
However, evidence that Golgi function per se is not linked
to lipid storage phenotypes, as well as direct association of
COPI members and regulators with the lipid droplet or PAT
proteins supports a more direct model. The COPI and COPII
pathways have established roles as constitutive vesicle trans-
port systems that cycle proteins as well as lipid from the Golgi
to the ER (COPI), or vice versa (COPII) [37]. Interference with
either of the COP trafﬁcking systems results in disturbed ER
and Golgi function [38,39]. The lipid overstorage phenotype
was only seen in the case of interference with COPI
trafﬁcking. This indicates that the lipid overstorage pheno-
type is not a simple consequence of ER and Golgi function.
Finally, in an indirect model in which COPI shuttles only
between the Golgi and the ER, COPI should not be lipid
droplet associated. However, COPI subunits are directly
associated with the lipid droplet surface as shown by
proteomics [6]. Additionally, Arf1 binds to ADRP, which is
exclusively associated with the lipid droplet surface [77].
Arf79F, the Drosophila homolog of mammalian Arf1, also
localizes to lipid droplets in Drosophila S2 cells [52].
We propose that COPI is likely to function directly at the
lipid droplet surface and not indirectly through the Golgi
(Figure 13). Perhaps COPI is a destination-speciﬁc trans-
porter returning lipid droplet surface hemimembrane and
Golgi membrane to the ER. The transport system that brings
nascent lipid droplets from the ER to the lipid droplet has
not been elucidated, but it is intriguing that the transport/
Figure 12. Changes in the Abundance of Selected Lipid Droplet Proteome Members Following BFA Treatment
(A and B) Mouse AML12 cells were grown in the presence of NEFA (400 lM oleic acid) overnight and incubated in DMSO (A) or 5 lM BFA in DMSO (B) for
6 h, prior to staining with antibodies detecting TIP47 (green channel) or ADRP (red channel). Separate images for the different channels as well as a
merged image are shown.
(C) Western blots of lipid droplet protein preparations. Lipid droplets from AML12 cells grown in the presence of 400 lM oleic acid and treated with
either DMSO (lanes one and three) or 5 lM BFA in DMSO (lanes two and four) were purified by sucrose gradient ultracentrifugation, and equal amounts
of the associated proteins were subjected to western blot. Two separate experiment replicates are represented. Band density ratios (6BFA) are given.
Scale bar in (A) represents 50 lm.
doi:10.1371/journal.pbio.0060292.g012
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COPI and Lipid StoragePAT protein TIP47 is found preferentially on small lipid
droplets. Small lipid droplets derived from the ER are
thought to help build larger droplets by fusion. TIP47-coated
droplets might form in the ER, and then COPI could return
TIP47 to the ER after the lipid cargo is deposited. In this
model, TIP47 becomes trapped at the lipid droplet surface in
the absence of COPI.
Although we observed increased TIP47 on ADRP-positive
droplets by both western blot and cell staining, the cell
staining result was more dramatic. Our model might also
explain why. The punctate staining of TIP47 in untreated
cells could be due to TIP47 on nascent droplets that might
also cofractionate with the larger ADRP-positive droplets in
the western blots, leading to a less dramatic enrichment for
TIP47 relative to ADRP in that experiment. However, we
cannot rule out other explanations, such as nonlinear
detection of antigen concentration or epitope masking in
the cell staining experiments.
COPI perturbation increases stored TG by decreasing the
lipolysis rate (this study, [52]) indicating that the wild-type
COPI complex promotes lipolysis. We have shown that COPI
directly or indirectly removes TIP47 from the lipid droplet
surface and promotes ATGL localization to the droplet
surface, where lipolysis occurs. ATGL has a key role in lipid
droplet utilization, and ATGL association with the droplet is
reduced by ADRP and Tip47 [68]. Our epistasis experiments
combining siRNA-mediated ATGL knockdown and BFA or
Exo1 compound treatment demonstrated that the decrease in
lipolysis rate is due to loss of ATGL activity. COPI activity
speciﬁcally alters lipid droplet surface composition by
increasing the amount of TIP47 and reducing the amount
of ATGL at ADRP-coated lipid droplets. We suggest that
COPI negatively regulates localization of TIP47. TIP47 in
turn prevents ATGL localization. The rescue of the double-
knockdown phenotype of TIP47 and ADRP by BFA or Exo1
suggests that COPI has an independent feed-forward effect
on ATGL levels at the lipid droplet surface.
Although we have focused our attention here on COPI, our
systematic and genome-wide exploration of gene functions
required for lipid storage in Drosophila signiﬁcantly increases
experimental access to the complex molecular processes
regulating lipid storage and utilization. Further, the use of
multiple screens using different cell types and different
organisms greatly increases conﬁdence in the genes in the
intersection. Given widespread concerns about RNAi screen-
ing efﬁcacy and off-target effects, as well as the time and
effort required for downstream analysis, systematic use of
multiple species and libraries to address a single biological
question might be cost effective in addition to resulting in
more durable datasets. Primary screens in Drosophila cells
followed by secondary screens in mouse cells are much less
expensive than a similar genome-wide screen in mammalian
cells. Additionally, the availability of mutants in most
Drosophila genes, along with demonstrated translation to
mammalian systems, provides a valuable entry point for in-
depth analyses in both ﬂy and mouse; and eventually for the
selection of therapeutic targets for emerging problems
associated with obesity and other metabolic disorders.
Figure 13. COPI Trafficking and Lipid Droplet Model
COPI and COPII trafficking systems shuttle proteins and lipids between ER and Golgi. Small TIP47-coated lipid droplets are born at the ER and reside in
the cytosol. The bigger lipid droplets are coated by ADRP, and TIP47 is returned to the ER. ATGL can translocate between the cytosol and the lipid
droplet surface, where it begins the conversion of TG to DG and eventually NEFA. Other TG lipases may also be present (indicated by the second arrow
liberating TG from the hydrophobic lipid droplet core). Wild-type Golgi–ER transport function of COPI might be necessary for proper lipid droplet
biogenesis at the ER. COPI could directly function at the lipid droplet surface, mediating a similar ER-targeted transport function as reported for the
Golgi–ER COPI transport. COPI is a positive regulator of ATGL with a unresolved mechanism (indicated by the question mark) and a negative regulator
of TIP47 lipid droplet localization. ADRP and TIP47 are negative regulators of ATGL activity at the lipid droplet surface.
doi:10.1371/journal.pbio.0060292.g013
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COPI and Lipid StorageMaterials and Methods
Genome-wide Drosophila RNAi screen wet-bench procedures. We
used the Harvard Drosophila RNAi Screening Center (DRSC, http://
www.ﬂyrnai.org) dsRNA collection, which covers more than 95% of
the transcriptome (Release 3.2 BDGP) with a total of 17,076 dsRNAs
[44] in duplicate. We seeded 1.5 3 10
4 Kc167 cells (DRSC) in 10 llo f
serum-free Schneider’s medium (GIBCO) in each well of microscopy-
quality 384-well plates containing the pre-aliquoted dsRNAs (ap-
proximately 250 ng of dsRNA/well). Plates were spun at 1,200 rpm for
1 min and incubated for 45 min at 25 8C. We then added 40 llo f
complete Schneider’s medium supplemented with 10% FCS (JRH
Biosciences), 50 units penicillin; and 50 lg of streptomycin/ml
(GIBCO) and 6400 lM oleic acid (Calbiochem) complexed to 0.4%
BSA (Sigma). Plates were sealed and incubated in a humidiﬁed
incubator at 25 8C for 4 d. The cells were subsequently ﬁxed for 10
min in 4% formaldehyde in PBS followed by a 10-min permeabiliza-
tion step in PBS including 0.1% Triton X-100. For lipid droplet
visualization and cell counting (nuclei), we incubated for 1 h with PBS
including 5 lg/ml BODIPY493/503 (Molecular Probes) and 5 lg/ml
DAPI or 5 lg/ml Hoechst33342 (Molecular Probes). After two washes
with PBS including 0.01% Tween-20, cells were kept in 40 ll of PBS
and visualized with a 203 objective on a Discovery1 automated
microscope system (Molecular Devices).
Secondary RNAi screen wet-bench procedures. A subset of 276
genes of the primary screen library were targeted by 362 additional
dsRNAs (Table S10) generated from PCR products obtained from the
Drosophila RNAi screening center of Harvard (DRSC). PCR fragments
were reampliﬁed using a modiﬁed T7 oligonucleotide (59-GTA ATA
CGA CTC ACT ATA GG-39) and a touchdown PCR protocol. PCR
products were subsequently used for in vitro transcription reactions
using T7 RNA polymerase (Fermentas). Following DNAse-mediated
digestion of the PCR template, dsRNAs were puriﬁed with Multi-
screen PCR puriﬁcation ﬁlter plates (Millipore). RNAi treatment was
performed either as described for the primary screen in optical-
quality 96-well plates (BD) with adjusted dsRNA and cell numbers, in
duplicate (approximately 1 lg of dsRNA and 5 3 10
4 cells/well).
Imaging was performed either with a BD Pathway 855 Bioimager
automated microscope (BD) or with a Zeiss Axiovert200M (Carl Zeiss)
and the OpenLab software (Improvision).
For the secondary mouse siRNA screen (Table S10), we used
AML12 murine liver cells (Steven Farmer, Boston University) and
3T3-L1 ﬁbroblast cells (ATCC) grown according to protocols of the
American Type Culture Collection (ATCC). Assays were done in 96-
multiwell plates (Fisher Scientiﬁc) at a density of 0.25 310
4 cells/well
on growth medium supplemented with 200 lM oleic acid, which was
added 18 h prior to ﬁxation of the cells. Cells were transfected with
Hiperfect transfection reagent (0.75 ll/well) (Qiagen) and exper-
imental or ALLStars negative control siRNA oligonucleotides (10
nM), according to the manufacturer’s instructions (Qiagen). Four
days after transfection, cells were ﬁxed and stained as described
above for the Drosophila cells and imaged with a BD Pathway 855
Bioimager automated microscope system (BD).
Image analysis. Images of Drosophila cells (two sites/well in the
primary screen; six sites/well for the secondary screen) were
processed with a custom image segmentation algorithm (available
from M. Beller upon request) written for the ImageJ software package
[78]. After a sharpening and a brightness/contrast adjustment (for the
BODIPY images; equal values for all images) or a gamma correction
(for the DAPI images; same values for all images), a background
subtraction followed by an Otsu thresholding step was run (Figure
1A–1D). Watershed processing to identify solitary particles followed.
Finally, lipid droplets or nuclei were identiﬁed with the generic
‘‘analyze particles’’ function of the ImageJ software with the following
settings: (1) settings for the nuclei: size from 10 to 10,000 pixels, 256
bins, outlines as well as measurement results displayed, measurements
on the edges excluded, clear results, ﬂood, and summary of the
results; and (2) settings for the lipid droplets: identical parameters
except size ranging from one to 200 pixels and a circularity from zero
to one. For each detected particle, the size and area were measured.
For each image, the total numbers of particles (‘‘counts’’)o r
cumulative measured area for all particles (‘‘area’’) are reported. A
custom Perl script concatenated the summarized measurements, and
the obtained information was used to calculate the ratio of lipid
droplets per cells as a measure of lipid storage (‘‘lipid droplet/nuclei
(area)’’ or ‘‘lipid droplet/nuclei (counts)’’).
Mammalian cell image analysis (four sites/well) was performed as
described above with some adjusted settings reﬂecting the larger
mammalian cell size as well as differences in imaging equipment (no
brightness or contrast adjustments were applied). The generic
‘‘analyze particles’’ function of the ImageJ software was used with
the following settings: (1) settings for the nuclei: size from 80 to
10,000 pixels, 256 bins, outlines as well as measurement results
displayed, measurements on the edges excluded, clear results, ﬂood,
and summary of the results; and (2) settings for the lipid droplets:
identical parameters, except the size ranging from one to 2,000 pixels
and a circularity from zero to one.
Primary screen data analysis. The general thrust of the analysis is
given below and is followed by a detailed description. Screen data are
available (Table S4; http://lipoﬂy.mpibpc.mpg.de/). Results were
robust to data handling method (Table S1). Genes passing thresh-
olding conditions (Tables S2 and S3) were used for the GO term
analysis (Table S5). B-score p-values can be used to further restrict the
gene lists shown in Tables S2 and S3.
Data analysis was performed with custom scripts written in the R
language and packages provided by the Bioconductor project [79].
The lipid droplets and nuclei area measurements of the two images
per well were used to calculate an averaged lipid area per nuclei area
value per well. Additionally to the primary images, a number of wells
required reimaging based on visual inspection (size of the complete
dataset: N ¼ 48,241 wells). To identify and extract images with bad
quality, the values for lipid droplet (LD) area and count measure-
ments as well as for the corresponding nuclei measurements of the
two images per well were plotted against each other to look for
variation within wells. In addition, the corresponding ‘‘LD area per
nuclei area’’ and ‘‘LD count per nuclei count’’ ratios were plotted
against each other per well. These plots showed 95 prominent
outliers (segmentation artifacts/‘‘bad’’ wells), which were removed
(resulting N ¼ 48,146 wells). The data values of reimaged wells were
averaged.
The screen dataset was platewise normalized for within-plate and
between-plate differences by four different algorithms. Because of
the limited number of controls per plate, 98% of the wells per plate
were used as a reference set in the normalization procedure as
proposed in [47] in which the largest and smallest 1% values of the
plate were removed to generate the reference set. Before data
normalization, LD areas per nuclei area ratios were log-transformed.
A classical robust Z-score normalization was performed ﬁrst [zi¼(xi 
medianj)/madj, where zi is the Z-score of well i; xi is the raw value of
well i; and medianj and madj are the median and median absolute
deviation (MAD) of the plate j] in addition to the recently proposed
strictly standardized mean difference normalization [SSMDi ¼ (xi  
meanj)/square root (2/nj   2.5 3 ((nj   1) 3 SDj2))]. Those related
algorithms were supplemented with both a ﬁtted linear model
normalization using the Prada package [45] and by B-score normal-
ization [46]. Benjamini and Hochberg FDR-corrected p-values for all
dsRNAs were calculated with the complete screen data (without the
largest and smallest 1%) as a reference set. Scoring was done both on
a platewise and screenwise manner. For the platewise hit identi-
ﬁcation, positives were identiﬁed by a quartile-based thresholding
algorithm [48]. For this purpose, the ﬁrst quartile (Q1), the median
(Q2), and the third quartile (Q3) were calculated ﬁrst. Afterwards,
threshold T were calculated [Tupper¼Q3þc3(Q3 Q2) and Tlower¼
Q1   c 3 (Q2   Q1), where c is a variable depending on the targeted
error rate] [48]. The same hit selection strategy was also chosen for
the screen-wide hit identiﬁcation among the linear model normalized
dataset. For the other normalization algorithms, ﬁxed thresholds
were selected. In all cases, threshold levels (as well as the c in the
quartile-based thresholding) were chosen based on the identiﬁcation
rates of the internal controls brummer dsRNA, midway dsRNA, and
wells with no oleic acid, which were present on every screening plate.
The highest possible threshold was chosen capable of balancing both
false-positive and -negative rates.
Identiﬁed Drosophila lipid regulating gene functions (Tables S2 and
S3) were subjected to in silico analysis for enriched GO terms. For
this purpose, we used the standard settings of the VLAD tool (Mouse
Genome Informatics Web site [51]) using the complete Drosophila
genome as a reference set. Results of the enrichment analyses were
visualized by pruned GO term networks (pruning threshold ¼ 4;
collapsing threshold ¼ 5), and results (pruning threshold ¼ 3;
collapsing threshold ¼ 6) are additionally tabulated (Table S5).
Detailed lists of the scoring genes were annotated with the
following information (Table S9): GO terms from FlyBase [80];
orthologs from FlyMine [81]; human disease gene orthologs from
Homophila (http://superﬂy.ucsd.edu/homophila/, used with a signiﬁ-
cance threshold of E , 1 3 10–50, [31]; InParanoid [82] orthologs
(http://inparanoid.sbc.su.se/cgi-bin/index.cgi); and Drosophila [4,33]; as
well as mammalian [5,6,32,34] lipid droplet subproteome data.
Secondary screen data analysis. A subset of genes identiﬁed in the
genome-wide screen with a potential function in cellular lipid storage
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genes were tested by targeting with 362 dsRNA sequences (Table S10).
Because we were interested in validating the full range of phenotypes
observed and not just the positives, we sampled across a broad range
of B-scores. We performed directed retesting on the genes encoding
COPI members. To test for COPI speciﬁcity, we used secondary
dsRNA sequences targeting Arf family members not involved in COPI
function as well as COPII vesicle transport encoding transcripts as
controls. dsRNAs targeting those genes did not result in a phenotype
in the primary screen. For a ‘‘positive’’ identiﬁcation, we required
that two independent nonoverlapping dsRNAs or siRNAs give the
same phenotype. In addition, we tested mouse AML12 hepatocytes
and mouse 3T3-L1 ﬁbroblasts for an evolutionary conservation of the
identiﬁed lipid storage modulators. Assuming that off-target effects
are random, this also minimizes misleading off-target effects, and is
certainly more stringent than the current standard of two positive
RNAi reagents with retesting in the same species and cell type [60]. In
total, 127 mouse genes covered by 312 siRNAs were tested (Table
S10). Genes across the screen that were validated using the image-
based analysis with additional RNAi reagents are listed in Table S7.
Additional gene and COPI validation comes from small compound
phenocopy, cell staining experiments, and measurements on lipid
metabolism as outlined further below.
Lipid droplet area and nuclei area measurements obtained from
the image segmentation procedure, which was carried out as
described for the primary screen results, was used to express the
ratio of lipid per cell. For each screen, plate data were median
normalized. In order to identify genes modulating lipid storage, a
basic thresholding of median 6 23MAD was used. Since the datasets
were enriched for modulators of lipid storage, the median as well as
MAD was calculated on the basis of control wells incorporated in the
assay plates. For the Drosophila, AML12, and 3T3-L1 datasets, those
wells contained no RNAi reagent, but were otherwise treated
identical to the experimental wells. Screening plates also contained
other control dsRNAs/siRNAs wells. The Drosophila secondary screen
plates contained wells with dsRNAs targeting bmm or mdy as in the
primary screen. In the case of the 3T3-L1 and AML12 cells, plates
contained siRNAs targeting Atgl or a combination of two siRNAs
targeting both Adrp and Tip47 transcripts [68]. Median 6 thresholds
were adjusted in order to fulﬁll the same prerequisites as in the
primary screen, namely a maximum of identiﬁed controls with a
minimum of false positives. False positives were scored based on the
wells lacking RNAi reagent.
Small-molecule compound-based modulation of cellular lipid
storage. Small-molecule compound experiments were performed
with embryonic Drosophila S3 cells (Bloomington Drosophila Stock
Center [DGRC]), which showed excellent oleic acid feeding character-
istics during RNAi assay development but inferior RNAi character-
istics as compared to the Kc167 cells. S3 cells showed superior
adherence during automated liquid handling in 1,536-well format.
We dispensed 4 ll of cells at 1.25 3 10
6 cells/ml into LoBase Aurora
COC 1,536-well plates (black walled, clear bottom) with a bottle-valve
solenoid-based dispenser (Aurora) to obtain 5,000 cells/well. A total of
23 nl of compound solution of different concentrations were
transferred to the assay plates using a Kalypsis pin tool equipped
with a 1,536-pin array containing 10-nl slotted pins (FP1S10, 0.457-
mm diameter, 50.8 mm long; V&P Scientiﬁc). One microliter of oleic
acid (400 lM) was added, and the plate was lidded with stainless steel
rubber gasket-lined lids containing pinholes. After 18–24-h incuba-
tion at 24 8C and 95% humidity, BODIPY 493/503 (Molecular Probes)
was added to the wells to stain lipid droplets, and the Cell Tracker
Red CMTPC dye (Molecular Probes) was added to enumerate cell
number. Fluorescence was detected by excitation of the ﬂuorophores
with a 488-nm laser on an Acumen Explorer (TTP Lab Tech). The
total intensity in channel 1 (500–530 nm) reﬂected lipid droplet
accumulation. Cells were detected using channel 3 (575–640 nm) with
5-lm width and 100-lm depth ﬁlters. The ratio of the total intensity
in PMT channel 1 over total intensity of channel 3 was also calculated.
Percent activity was computed relative to an internal control (100%
inhibited lipid droplet deposition due to the presence of 20 lM
Triacsin C), which was added to 32 wells/plate.
Lipolysis and lipogenesis measurements in AML12 cells. Measure-
ments of NEFA released from lipid droplets or incorporated into the
TG fraction were performed as previously described [23,68,83].
Brieﬂy, AML12 cells treated with or without speciﬁc siRNAs (10
nM) for 4 d were incubated overnight with growth medium
supplemented with 400 lM oleic acid complexed to 0.4% bovine
serum albumin to promote triacylglycerol deposition and [3H] oleic
acid, at 1 3 10
6 dpm/well, was included as a tracer. In lipolysis
experiments, re-esteriﬁcation of fatty acids in AML12 cells was
prevented by including 10 lM Triacsin C (Biomol), an inhibitor of
acyl coenzyme A synthetase [67], in the medium. Quadruplicate wells
were tested for each condition. Lipolysis was determined by
measuring radioactivity released into the media in 1 h. For the lipid
extraction and thin layer chromatography, the cell monolayer was
washed with ice-cold PBS and scraped into 1 ml of PBS. Lipids were
extracted by the Bligh-Dyer method [84], and 10% of the total lipid
was analyzed by thin layer chromatography [83,85]. AML12 cells
treated with or without speciﬁc siRNAs were additionally incubated
with either vehicle (DMSO), 5 lM of Exo1 (12.5 mg/ml DMSO), or BFA
(10 mg/ml DMSO) during the time of radioactivity release into the
media (2 h). NEFA incorporation into the TG fraction and NEFA
release are calculated as nanomoles/milligram protein (Table S8).
Protein measurements were performed using a commercial BCA
assay kit (Pierce Biotechnology) according to the manufacturer’s
instructions. Statistical signiﬁcance was tested by impaired Student t
test (GraphPad software).
Antibodies. Rabbit anti-TIP47 and goat anti-ADRP were used as
previously published [9]. Antibodies targeting mouse ATGL were
purchased from Cell Signaling Technology. The CGI-58 antibody was
a gift from Dr. Osumi [29].
Immunocytochemistry. Cells were plated in four-well Lab-Tek
chamber slides (Nunc) and incubated overnight with 400 lM oleic
acid. In compound experiments, wells received vehicle (DMSO) or 5
lM BFA (10 mg/ml DMSO) treatment for 6 h. RNAi treatment prior
to immunocytochemistry is outlined above. For ADRP and TIP47
staining, cells were ﬁxed in 3% v/v paraformaldhyde/PBS for 15 min
at room temperature. Staining was performed by published methods
[9,86]. Cells were viewed with a confocal laser scanning microscope
(LSM510; Carl Zeiss MicroImaging) using a 633 oil objective lens.
Fat cake preparation. Eight 100-mm dishes for each condition were
treated with 400 lM oleic acid overnight and further treated with
DMSO or BFA (5 lM) for 6 h on the next day. Cells were washed three
times with phosphate buffered saline (PBS; pH 7.4), scraped into PBS,
and then pelleted by low-speed centrifugation. LD isolation was as
reported [8]. The lipid fat cake was isolated and resuspended in 150 ll
of PBS containing 5% SDS before 150 llo f2 3 Laemmli sample
buffer were added. For CGI-58 and ATGL western blots, those
protein extracts were directly loaded. For ADRP and Tip47, the
samples were diluted 200-fold (ADRP) or 20-fold (TIP47), respec-
tively. A total of 35 ll were loaded then on each lane. X-ray ﬁlms were
used to detect the western blots. Quantiﬁcation was done with ImageJ
[78].
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Drosophila RNAi screen hits: FBgn0000028, FBgn0000042,
FBgn0000114, FBgn0000339, FBgn0000489, FBgn0000547,
FBgn0000567, FBgn0001186, FBgn0001204, FBgn0001301,
FBgn0002878, FBgn0003048, FBgn0003118, FBgn0003339,
FBgn0003380, FBgn0003392, FBgn0003462, FBgn0003557,
FBgn0003607, FBgn0003691, FBgn0004167, FBgn0004187,
FBgn0004401, FBgn0004587, FBgn0004595, FBgn0004611,
FBgn0004652, FBgn0004797, FBgn0004838, FBgn0004856,
FBgn0004879, FBgn0005411, FBgn0005626, FBgn0005630,
FBgn0010083, FBgn0010215, FBgn0010355, FBgn0010638,
FBgn0010750, FBgn0011571, FBgn0011701, FBgn0013746,
FBgn0014020, FBgn0015320, FBgn0015818, FBgn0015919,
FBgn0016926, FBgn0016940, FBgn0019643, FBgn0020611,
FBgn0020908, FBgn0021768, FBgn0022246, FBgn0023143,
FBgn0024285, FBgn0024308, FBgn0024555, FBgn0024754,
FBgn0025638, FBgn0026206, FBgn0026317, FBgn0026620,
FBgn0026722, FBgn0026878, FBgn0027495, FBgn0027589,
FBgn0027885, FBgn0027951, FBgn0028360, FBgn0028420,
FBgn0028982, FBgn0029123, FBgn0029526, FBgn0029661,
FBgn0029731, FBgn0029766, FBgn0029824, FBgn0029850,
FBgn0029873, FBgn0029935, FBgn0030075, FBgn0030077,
FBgn0030087, FBgn0030093, FBgn0030189, FBgn0030244,
FBgn0030390, FBgn0030434, FBgn0030492, FBgn0030608,
FBgn0030872, FBgn0030904, FBgn0031008, FBgn0031030,
FBgn0031031, FBgn0031074, FBgn0031093, FBgn0031232,
FBgn0031390, FBgn0031518, FBgn0031626, FBgn0031673,
FBgn0031816, FBgn0031836, FBgn0031888, FBgn0031894,
FBgn0032049, FBgn0032340, FBgn0032351, FBgn0032360,
FBgn0032363, FBgn0032388, FBgn0032454, FBgn0032622,
FBgn0032800, FBgn0032868, FBgn0032945, FBgn0033155,
FBgn0033160, FBgn0033541, FBgn0034071, FBgn0034402,
FBgn0034646, FBgn0034709, FBgn0034839, FBgn0034946,
FBgn0034967, FBgn0035085, FBgn0035136, FBgn0035294,
FBgn0035546, FBgn0035569, FBgn0035631, FBgn0036274,
FBgn0036374, FBgn0036470, FBgn0036556, FBgn0036734,
FBgn0036761, FBgn0036811, FBgn0037024, FBgn0037149,
FBgn0037178, FBgn0037250, FBgn0037278, FBgn0037304,
FBgn0037568, FBgn0037920, FBgn0037924, FBgn0038168,
FBgn0038191, FBgn0038343, FBgn0038359, FBgn0038391,
FBgn0038592, FBgn0038633, FBgn0038662, FBgn0039054,
FBgn0039941, FBgn0039959, FBgn0039997, FBgn0040279,
FBgn0040291, FBgn0040369, FBgn0040534, FBgn0040651,
FBgn0040777, FBgn0042693, FBgn0050126, FBgn0050470,
FBgn0051313, FBgn0051374, FBgn0051632, FBgn0051814,
FBgn0052056, FBgn0052062, FBgn0052112, FBgn0052121,
FBgn0052150, FBgn0052202, FBgn0052352, FBgn0052397,
FBgn0052440, FBgn0052635, FBgn0052704, FBgn0052710,
FBgn0052711, FBgn0052970, FBgn0053207, FBgn0053500,
FBgn0053516, FBgn0058413, FBgn0061200, FBgn0083976,
FBgn0083992, FBgn0085381, FBgn0086441, FBgn0086674,
FBgn0086899, FBgn0243486, FBgn0259162, FBgn0259169,
FBgn0259171, FBgn0259217, FBgn0259228, FBgn0259240,
FBgn0259243, FBgn0000008, FBgn0000100, FBgn0000116,
FBgn0000212, FBgn0000409, FBgn0000492, FBgn0000636,
FBgn0000986, FBgn0001133, FBgn0001216, FBgn0001217,
FBgn0001218, FBgn0001942, FBgn0002023, FBgn0002590,
FBgn0002593, FBgn0002607, FBgn0002906, FBgn0002921,
FBgn0003031, FBgn0003060, FBgn0003209, FBgn0003277,
FBgn0003279, FBgn0003360, FBgn0003600, FBgn0003687,
FBgn0003701, FBgn0003941, FBgn0003942, FBgn0004110,
FBgn0004922, FBgn0004926, FBgn0005593, FBgn0005614,
FBgn0005630, FBgn0005648, FBgn0008635, FBgn0010078,
FBgn0010220, FBgn0010348, FBgn0010352, FBgn0010391,
FBgn0010409, FBgn0010410, FBgn0010412, FBgn0010431,
FBgn0010612, FBgn0010808, FBgn0011211, FBgn0011272,
FBgn0011284, FBgn0011701, FBgn0011726, FBgn0011745,
FBgn0011837, FBgn0012034, FBgn0013275, FBgn0013276,
FBgn0013277, FBgn0013278, FBgn0013279, FBgn0013325,
FBgn0013981, FBgn0014020, FBgn0014857, FBgn0015024,
FBgn0015288, FBgn0015393, FBgn0015756, FBgn0015774,
FBgn0015778, FBgn0015834, FBgn0016120, FBgn0016694,
FBgn0016926, FBgn0017397, FBgn0017545, FBgn0017566,
FBgn0017579, FBgn0019624, FBgn0019886, FBgn0019936,
FBgn0020129, FBgn0020386, FBgn0020439, FBgn0020910,
FBgn0022343, FBgn0022935, FBgn0023170, FBgn0023171,
FBgn0023213, FBgn0023531, FBgn0024150, FBgn0024330,
FBgn0024733, FBgn0024939, FBgn0025286, FBgn0025582,
FBgn0025724, FBgn0025725, FBgn0026262, FBgn0026666,
FBgn0026741, FBgn0027321, FBgn0027348, FBgn0027615,
FBgn0028530, FBgn0028867, FBgn0028968, FBgn0028969,
FBgn0029088, FBgn0029161, FBgn0029504, FBgn0029761,
FBgn0029799, FBgn0029822, FBgn0029860, FBgn0029897,
FBgn0030025, FBgn0030088, FBgn0030174, FBgn0030259,
FBgn0030341, FBgn0030384, FBgn0030386, FBgn0030606,
FBgn0030610, FBgn0030669, FBgn0030692, FBgn0030696,
FBgn0030726, FBgn0030915, FBgn0030951, FBgn0030990,
FBgn0031300, FBgn0031392, FBgn0031545, FBgn0031696,
FBgn0031771, FBgn0031842, FBgn0031980, FBgn0032053,
FBgn0032215, FBgn0032261, FBgn0032330, FBgn0032400,
FBgn0032518, FBgn0032587, FBgn0032596, FBgn0032619,
FBgn0032656, FBgn0032675, FBgn0032833, FBgn0032987,
FBgn0033029, FBgn0033081, FBgn0033085, FBgn0033282,
FBgn0033313, FBgn0033341, FBgn0033368, FBgn0033379,
FBgn0033403, FBgn0033591, FBgn0033652, FBgn0033699,
FBgn0033902, FBgn0033912, FBgn0034020, FBgn0034258,
FBgn0034487, FBgn0034488, FBgn0034537, FBgn0034579,
FBgn0034649, FBgn0034751, FBgn0034902, FBgn0034948,
FBgn0034968, FBgn0034987, FBgn0035276, FBgn0035315,
FBgn0035422, FBgn0035562, FBgn0035563, FBgn0035638,
FBgn0035699, FBgn0035753, FBgn0035872, FBgn0035976,
FBgn0036135, FBgn0036213, FBgn0036288, FBgn0036343,
FBgn0036351, FBgn0036360, FBgn0036398, FBgn0036449,
FBgn0036462, FBgn0036492, FBgn0036532, FBgn0036534,
FBgn0036576, FBgn0036613, FBgn0036728, FBgn0036820,
FBgn0036825, FBgn0036895, FBgn0036990, FBgn0037010,
FBgn0037028, FBgn0037093, FBgn0037097, FBgn0037098,
FBgn0037102, FBgn0037207, FBgn0037249, FBgn0037270,
FBgn0037356, FBgn0037415, FBgn0037429, FBgn0037529,
FBgn0037546, FBgn0037559, FBgn0037566, FBgn0037610,
FBgn0037637, FBgn0037752, FBgn0037813, FBgn0037912,
FBgn0037942, FBgn0037955, FBgn0038049, FBgn0038074,
FBgn0038131, FBgn0038281, FBgn0038345, FBgn0038538,
FBgn0038628, FBgn0038629, FBgn0038734, FBgn0038760,
FBgn0038881, FBgn0038996, FBgn0039205, FBgn0039214,
FBgn0039302, FBgn0039359, FBgn0039402, FBgn0039404,
FBgn0039464, FBgn0039520, FBgn0039580, FBgn0039857,
FBgn0040007, FBgn0040010, FBgn0040233, FBgn0040512,
FBgn0040529, FBgn0040634, FBgn0040766, FBgn0040793,
FBgn0043001, FBgn0043904, FBgn0050007, FBgn0050290,
FBgn0050387, FBgn0051158, FBgn0051284, FBgn0051291,
FBgn0051302, FBgn0051354, FBgn0051361, FBgn0051450,
FBgn0051453, FBgn0051554, FBgn0051613, FBgn0051754,
FBgn0051774, FBgn0051847, FBgn0052050, FBgn0052105,
FBgn0052179, FBgn0052193, FBgn0052219, FBgn0052311,
FBgn0052600, FBgn0052633, FBgn0052720, FBgn0052733,
FBgn0052773, FBgn0052778, FBgn0052797, FBgn0053128,
FBgn0053147, FBgn0053256, FBgn0053271, FBgn0053300,
FBgn0053319, FBgn0058337, FBgn0062412, FBgn0062413,
FBgn0083950, FBgn0085392, FBgn0085408, FBgn0085424,
FBgn0085436, FBgn0086710, FBgn0086712, FBgn0086758,
FBgn0086904, FBgn0250791, FBgn0250814, FBgn0250834,
FBgn0250908, FBgn0259113, FBgn0259212, FBgn0259232, and
FBgn0259246.
Mouse genes with a conﬁrmed function in lipid storage regulation:
MGI:107807, MGI:107851, MGI:1333825, MGI:1334462, MGI:1335073,
MGI:1351329, MGI:1353495, MGI:1354962, MGI:1858696,
MGI:1861607, MGI:1891824, MGI:1891829, MGI:1913585,
MGI:1914062, MGI:1914103, MGI:1914144, MGI:1914234,
MGI:1914454, MGI:1915822, MGI:1916296, MGI:1917599,
MGI:1929063, MGI:2385261, MGI:2385656, MGI:2387591,
MGI:2388481, MGI:2443241, MGI:3041174, MGI:3694697, MGI:88192,
MGI:95301, MGI:98342, and MGI:99431.
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